Centers | ||
|
|
|
Chulalongkorn University Drug Discovery and Drug Development Research Center (Chula4DR) | Chemical Genomics Facility at Purdue Institute for Drug Discovery | Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI) |
Chulalongkorn
Drug Discovery and Drug Development Research Center (Chula4DR) was
established in 2017, with the aim to facilitate advancement of academic
drug discovery and drug development research by leveraging innovations
and sciences... Read more |
The Chemical Genomics Facility is a core facility at Purdue Institute for Drug Discovery that provides expertise and resources needed in the early stage of drug discovery. The services include small molecule libraries, access to automated equipment... Read more |
The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main... |
Partnerships |
Events |
Jobs |
JDRF & Novo Nordisk to Collaborate on Type 1 DiabetesJDRF and Novo Nordisk have entered into collaboration to develop new immunotherapies to treat Type 1 diabetes. The new partnership will be based out of Novo's newly opened Type 1 Diabetes R&D Center in Seattle. JDRF and Novo Nordisk will be... View all Merck Establishes New Center in San Diego with Academic ResearchersMerck Pharmaceuticals has committed to fund $90 million over period of seven years to establish California Institute for Biomedical Research (Calibr) in San Diego, California. The new center will be led by Peter Schulz from the Scripps Research... View all Sanofi to Collaborate with UCSF to Develop New Drugs to Treat DiabetesUniversity of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep biology expertise at Sanofi will be partnering with... View all |
No EVENTS for listing |
No Job Posts |
